Drawing based on the description in the official product monograph. No photo yet.
“15 mg tablets: Each light blue, elliptical biconvex film-coated tablet, engraved "APO" on one side and "OLA 15" on the other side, contains 15 mg of olanzapine”
APO OLA 15 pill
Pill with imprint APO OLA 15 is blue, oval and has been identified as Olanzapine 15 mg. It is used for bipolar disorder, schizophrenia and psychosis. It is supplied by Sivem Pharmaceuticals ULC.
Sold in Canada
Olanzapine 15 mg
- Imprint
- APO OLA 15
- Strength
- 15 mg
- Used for
- Bipolar disorder, schizophrenia and psychosis
- Color
- Blue
- Shape
- Oval
- Form
- Tablet
- Manufacturer
- Sivem Pharmaceuticals ULC
- Drug class
- Antipsychotic (atypical)
- Sold in
- Canada
- DIN
- 02385902
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Olanzapine used for?
Olanzapine is used for bipolar disorder, schizophrenia and psychosis.
- Medicine type
- Antipsychotic (atypical)
Official uses from the US prescribing label
Schizophrenia
Oral olanzapine tablets are indicated for the treatment of schizophrenia. Efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. In adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6-week trial.
When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents.
Bipolar I Disorder (Manic or Mixed Episodes)
Monotherapy — Oral olanzapine tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. Efficacy was established in three clinical trials in adult patients with manic or mixed episodes of bipolar I disorder: two 3- to 4-week trials and one monotherapy maintenance trial. In adolescent patients with manic or mixed episodes associated with bipolar I disorder (ages 13 to 17), efficacy was established in one 3-week trial.
When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents.
Adjunctive Therapy to Lithium or Valproate — Oral olanzapine tablets are indicated for the treatment of manic or mixed episodes associated with bipolar I disorder as an adjunct to lithium or valproate. Efficacy was established in two 6-week clinical trials in adults. The effectiveness of adjunctive therapy for longer-term use has not been systematically evaluated in controlled trials.
Special Considerations in Treating Pediatric Schizophrenia and Bipolar I Disorder
Pediatric schizophrenia and bipolar I disorder are serious mental disorders; however, diagnosis can be challenging. For pediatric schizophrenia, symptom profiles can be variable, and for bipolar I disorder, pediatric patients may have variable patterns of periodicity of manic or mixed symptoms. It is recommended that medication therapy for pediatric schizophrenia and bipolar I disorder be initiated only after a thorough diagnostic evaluation has been performed and careful consideration given to the risks associated with medication treatment. Medication treatment for both pediatric schizophrenia and bipolar I disorder should be part of a total treatment program that often includes psychological, educational and social interventions.
Olanzapine Tablets and Fluoxetine in Combination: Depressive Episodes Associated with Bipolar I Disorder
Oral olanzapine tablets and fluoxetine in combination is indicated for the treatment of depressive episodes associated with bipolar I disorder, based on clinical studies. When using olanzapine tablets and fluoxetine in combination, refer to the Clinical Studies section of the package insert for Symbyax.
Olanzapine monotherapy is not indicated for the treatment of depressive episodes associated with bipolar I disorder.
Olanzapine Tablets and Fluoxetine in Combination: Treatment Resistant Depression
Oral olanzapine and fluoxetine in combination is indicated for the treatment of treatment resistant depression (major depressive disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode), based on clinical studies in adult patients. When using olanzapine and fluoxetine in combination, refer to the Clinical Studies section of the package insert for Symbyax.
Olanzapine monotherapy is not indicated for the treatment of treatment resistant depression.
From the FDA-approved label on DailyMed (published Sep 24, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows APO OLA 15. The parts can be split between the two sides, so turn the pill over and check both.
- It is blue, oval.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Olanzapine by Sivem Pharmaceuticals ULC.
In Canada: prescription only.
Ingredients
Active: Olanzapine
Other pills with imprint APO OLA 15
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
LAC 200
Lacosamide 200 mg
Blue, oval, 17 mm
Used for focal seizures and tonic-clonic seizures
Schedule V
-
AN 441
Meclizine Hydrochloride 12.5 mg
Blue, oval, 10 mm
Used for dizziness (vertigo) and motion sickness
-
OPC 50
Opicapone 50 mg
Blue, oval, 19 mm
Used for Parkinson's disease
-
OPC 25
Opicapone 25 mg
Blue, oval, 19 mm
Used for Parkinson's disease
-
765 4 AN
Warfarin 4 mg
Blue, oval, 11 mm
Used for atrial fibrillation (irregular heartbeat) and stroke
-
765 4 AN
Warfarin Sodium 4 mg
Blue, oval, 11 mm
Used for atrial fibrillation (irregular heartbeat) and stroke
Other Olanzapine pills
-
R10 0166
Olanzapine 10 mg
White, oval, 10 mm
Used for bipolar disorder and schizophrenia
-
R15 0167
Olanzapine 15 mg
White, round, 10 mm
Used for bipolar disorder and schizophrenia
-
R 2 5 0163
Olanzapine 2.5 mg
White, oval, 8 mm
Used for bipolar disorder and schizophrenia
-
R20 0168
Olanzapine 20 mg
White, oval, 15 mm
Used for bipolar disorder and schizophrenia
-
R5 0164
Olanzapine 5 mg
White, oval, 8 mm
Used for bipolar disorder and schizophrenia
- LILLY 4117 Olanzapine 10 mg White, round, 10 mm Used for bipolar disorder and schizophrenia
- TEVA 5770 Olanzapine 10 mg White, round, 10 mm Used for bipolar disorder and schizophrenia
- 10 Olanzapine 10 mg Yellow, oval, 12 mm Used for bipolar disorder and schizophrenia